TABLE 2

Enzyme kinetic parameters for formation of clozapine metabolites by HLM and recombinant human CYP3A4 and CYP2D6

MetaboliteKinetic ParametersEnzyme Fractions
CYP3A4CYP2D6Pooled HLM
Total GSH conjugatesKM (µM)30.3 ± 5.121.9 ± 2.7126 ± 22
Vmax (nmol/min/nmol P450)3.1 ± 0.12.8 ± 0.11266 ± 89a
Vmax/KM (ml/min/nmol P450; ×103)101.9128.810071b
Clozapine N-OxideKM (µM)92.7 ± 5.584.1 ± 3.9250 ± 39
Vmax (nmol/min/nmol P450)9.5 ± 0.26.1 ± 0.12130 ± 164a
Vmax/KM (ml/min/nmol P450; ×103)102.572.88516b
N-Demethyl ClozapineKM (µM)47.6 ± 4.425.3 ± 0.4268 ± 37
Vmax (nmol/min/nmol P450)19.9 ± 0.632.8 ± 0.23215 ± 226a
Vmax/KM (ml/min/nmol P450; ×103)419129811974b
  • GSH, glutathione; HLM, human liver microsomes.

  • a Vmax values for HLM are expressed as nmol/min/mg protein.

  • b Vmax/KM values for HLM are expressed in ml/min/mg protein.